The β-galactoside α2,6 sialyltransferase 1 (ST6Gal1), an enzyme catalyzing the α2,6 sialylation on N-glycans, has been well investigated because the altered expression of ST6Gal1 is observed in many kinds of cancer cells and tissues [22–24]. The gene discussed is ST6GAL1; the disease is cancer.